Cleared Traditional

K200690 - LifeSignals ECG Remote Monitoring Patch...

K200690 is an FDA 510(k) clearance for LifeSignals ECG Remote Monitoring Patch..., manufactured by Lifesignals, Inc.. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 121-day FDA review.

K200690 · Lifesignals, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
121d
Days
Class 2
Risk

K200690 is an FDA 510(k) clearance for the LifeSignals ECG Remote Monitoring Patch Platform. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Lifesignals, Inc. (Fremont, US). The FDA issued a Cleared decision on July 15, 2020 after a review of 121 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Lifesignals, Inc. devices

FDA 510(k) Submission Details - K200690

510(k) Number K200690 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 16, 2020
Decision Date July 15, 2020
Days to Decision 121 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 125d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 73
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K200690.
LifePath Remote Patient Monitoring Platform
K211822 · Elastic Care Incorporated · Feb 2022
ANNE One
K211305 · Sibel, Inc. · Sep 2021
LifeSignals Multi-Parameter Remote Monitoring Platform
K202868 · Lifesignals, Inc. · Jul 2021
Vitls Platform
K191620 · Vitls, Inc. · Jun 2020
Vista Solution Monitoring Kit, Vista Solution 2 10-day Evaluation Kit, VistaTablet 2 (Boxed)
K193343 · Vitalconnect, Inc. · Apr 2020
Philips Biosensor BX100
K192875 · Philips Medical Systems · Apr 2020